Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.

Background:<br/> Point-of-care (POC) devices could be used to measure hemoglobin A1c (HbA1c) in the doctors’ office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical performance of some of these devices. We carried out a systematic review a...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Hirst, J, McLellan, J, Price, C, English, E, Feakins, B, Stevens, R, Farmer, A
Μορφή: Journal article
Γλώσσα:English
Έκδοση: De Gruyter 2016
_version_ 1826268061959716864
author Hirst, J
McLellan, J
Price, C
English, E
Feakins, B
Stevens, R
Farmer, A
author_facet Hirst, J
McLellan, J
Price, C
English, E
Feakins, B
Stevens, R
Farmer, A
author_sort Hirst, J
collection OXFORD
description Background:<br/> Point-of-care (POC) devices could be used to measure hemoglobin A1c (HbA1c) in the doctors’ office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical performance of some of these devices. We carried out a systematic review and meta-analysis using a novel approach to compare the accuracy and precision of POC HbA1c devices. <br/><br/> Methods: <br/> Medline, Embase and Web of Science databases were searched in June 2015 for published reports comparing POC HbA1c devices with laboratory methods. Two reviewers screened articles and extracted data on bias, precision and diagnostic accuracy. Mean bias and variability between the POC and laboratory test were combined in a meta-analysis. Study quality was assessed using the QUADAS2 tool. <br/><br/> Results: <br/> Two researchers independently reviewed 1739 records for eligibility. Sixty-one studies were included in the meta-analysis of mean bias. Devices evaluated were A1cgear, A1cNow, Afinion, B-analyst, Clover, Cobas b101, DCA 2000/Vantage, HemoCue, Innovastar, Nycocard, Quo-Lab, Quo-Test and SDA1cCare. Nine devices had a negative mean bias which was significant for three devices. There was substantial variability in bias within devices. There was no difference in bias between clinical or laboratory operators in two devices. <br/><br/> Conclusions: <br/> This is the first meta-analysis to directly compare performance of POC HbA1c devices. Use of a device with a mean negative bias compared to a laboratory method may lead to higher levels of glycemia and a lower risk of hypoglycaemia. The implications of this on clinical decision-making and patient outcomes now need to be tested in a randomized trial.
first_indexed 2024-03-06T21:03:49Z
format Journal article
id oxford-uuid:3bc7c9b8-3fdb-4d3f-aa48-8d6863af360f
institution University of Oxford
language English
last_indexed 2024-03-06T21:03:49Z
publishDate 2016
publisher De Gruyter
record_format dspace
spelling oxford-uuid:3bc7c9b8-3fdb-4d3f-aa48-8d6863af360f2022-03-26T14:09:33ZPerformance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3bc7c9b8-3fdb-4d3f-aa48-8d6863af360fEnglishSymplectic Elements at OxfordDe Gruyter2016Hirst, JMcLellan, JPrice, CEnglish, EFeakins, BStevens, RFarmer, ABackground:<br/> Point-of-care (POC) devices could be used to measure hemoglobin A1c (HbA1c) in the doctors’ office, allowing immediate feedback of results to patients. Reports have raised concerns about the analytical performance of some of these devices. We carried out a systematic review and meta-analysis using a novel approach to compare the accuracy and precision of POC HbA1c devices. <br/><br/> Methods: <br/> Medline, Embase and Web of Science databases were searched in June 2015 for published reports comparing POC HbA1c devices with laboratory methods. Two reviewers screened articles and extracted data on bias, precision and diagnostic accuracy. Mean bias and variability between the POC and laboratory test were combined in a meta-analysis. Study quality was assessed using the QUADAS2 tool. <br/><br/> Results: <br/> Two researchers independently reviewed 1739 records for eligibility. Sixty-one studies were included in the meta-analysis of mean bias. Devices evaluated were A1cgear, A1cNow, Afinion, B-analyst, Clover, Cobas b101, DCA 2000/Vantage, HemoCue, Innovastar, Nycocard, Quo-Lab, Quo-Test and SDA1cCare. Nine devices had a negative mean bias which was significant for three devices. There was substantial variability in bias within devices. There was no difference in bias between clinical or laboratory operators in two devices. <br/><br/> Conclusions: <br/> This is the first meta-analysis to directly compare performance of POC HbA1c devices. Use of a device with a mean negative bias compared to a laboratory method may lead to higher levels of glycemia and a lower risk of hypoglycaemia. The implications of this on clinical decision-making and patient outcomes now need to be tested in a randomized trial.
spellingShingle Hirst, J
McLellan, J
Price, C
English, E
Feakins, B
Stevens, R
Farmer, A
Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.
title Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.
title_full Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.
title_fullStr Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.
title_full_unstemmed Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.
title_short Performance of point-of-care HbA1c test devices: implications for use in clinical practice - a systematic review and meta-analysis.
title_sort performance of point of care hba1c test devices implications for use in clinical practice a systematic review and meta analysis
work_keys_str_mv AT hirstj performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis
AT mclellanj performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis
AT pricec performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis
AT englishe performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis
AT feakinsb performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis
AT stevensr performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis
AT farmera performanceofpointofcarehba1ctestdevicesimplicationsforuseinclinicalpracticeasystematicreviewandmetaanalysis